An observational study in Arthritic Psoriasis, Psoriasis (PsO) and Retinal Vessels, sponsored by Bursa Yuksek Ihtisas Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by Bursa Yuksek Ihtisas Training and Research Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Arthritis, Psoriatic with a site in Turkey — 6 open to participants now, 10 under way, 4 of them phase 3. Arthritis, Psoriatic · Turkey.
Among the 31 studies in Arthritis, Psoriatic with a site in Turkey, this one is the 4th largest by planned enrollment of the 15 observational ones that give a count, is one of 2 that started in 2026, is one of 15 observational ones, and was the 31st registered.
602 studies on the registry are indexed under Arthritis, Psoriatic; 129 are open to participants now.
Browse Arthritis, Psoriatic studies →6 of the 31 studies in Arthritis, Psoriatic with a site in Turkey are open now. Recruiting first, the newest first:
Marmara University · Sites in Turkey
Ages 18–65
Janssen Research & Development, LLC · Sites in Turkey, United States, Argentina and 15 more countries
Ages 3+
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18–65 · Healthy volunteers
Izmir Katip Celebi University · Sites in Turkey
Ages 18–65 · Women only
Bezmialem Vakif University · Sites in Turkey
Ages 18–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 89 Arthritis, Psoriatic studies recruiting now, 52 (58%) set no upper age limit and 28 (31%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 135 is below the median of 280 across 244 observational studies indexed under Arthritis, Psoriatic.
Median enrollment 289 across the 16 interventional studies, 90 across the 15 observational. Of the 21 that completed or were terminated, 5 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 31 have an industry lead sponsor. The 10 most frequent:
Bursa Yuksek Ihtisas Training and Research Hospital is the lead sponsor of 53 studies on the registry; 23 are open to participants now.
Bursa Yuksek Ihtisas Training and Research Hospital has 1 study filed under Arthritis, Psoriatic — fewer than ten, so there is no comparison to draw.
5 of the studies in Arthritis, Psoriatic with a site in Turkey that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06807424Phase 3Janssen Research & Development, LLCA Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis | 2027-02-10 |
| NCT05092269Phase 3Janssen Research & Development, LLCA Long-term Extension Study of Ustekinumab in Pediatric Participants | 2027-09-29 |
| NCT04929210Janssen Research & Development, LLCA Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease | 2027-04-01 |
| NCT07653009Marmara UniversityTranscutaneous Auricular Vagus Nerve Stimulation in Psoriatic Arthritis | 2027-06-02 |
| NCT07858591Bursa Yuksek Ihtisas Training and Research HospitalRetinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With Psoriatic Arthritis: A Case-Control Study. | 2027-08-20 |
Add all 5 to your calendar (.ics) → With an account.
Among the 31 studies in Arthritis, Psoriatic with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In terms of blood flow per unit of tissue, the retina is one of the tissues with the highest blood flow in the body. Parameters such as the thickness of the choroid layer, which plays a crucial role in maintaining normal eye function, the dimensions of the foveal avascular zone (FAZ) supplied by this layer, and retinal vascular networks can be measured using non-invasive methods. OCTA (Optical Coherence Tomography Angiography) is an imaging tool that enables the non-invasive assessment of retinal microvascular densities and the measurement of the foveal avascular zone's dimensions. Studies conducted to date indicate that retinal capillary vessels and the dimensions of the foveal avascular zone are affected in rheumatological diseases, especially associated with systemic inflammation. This study aims to compare retinal capillary vessel density and foveal avascular zone dimensions in patients with psoriatic arthritis against those in a healthy population and in patients with psoriasis who do not have psoriatic arthritis, utilizing the non-invasive method of optical coherence tomography angiography.
In terms of blood flow per unit of tissue, the retina is one of the tissues with the highest blood flow in the body. Non-invasive methods allow for the measurement of-and the detection of changes in-the thickness of the choroid layer (which plays a crucial role in maintaining normal eye function), the foveal avascular zone (nourished by this layer), and the retinal vascular networks. OCTA (Optical Coherence Tomography Angiography) is an imaging tool capable of non-invasively assessing retinal microvascular densities and measuring the dimensions of the foveal avascular zone. Retinal microvascular structures can be affected by systemic pathologies, including various eye diseases. In recent years, there has been growing evidence indicating that retinal vessel densities-as detected by OCTA-are significantly altered and the dimensions of the foveal avascular zone differ in patients with connective tissue diseases, vasculitis, and spondylitis. Psoriatic arthritis is a common chronic inflammatory disease characterized by both spondyloarthropathy and peripheral arthritis involvement. There is currently no data in the literature regarding the status of the choroidal vasculature-a highly perfused tissue-in patients with psoriatic arthritis or its relationship with disease activity. In this study, we aimed to compare retinal capillary density and foveal avascular zone dimensions among patients with psoriatic arthritis, patients with psoriasis, and healthy individuals using OCTA. The study will also compare findings between subgroups of psoriatic patients with and without concomitant spondylitis.
The study population consists of volunteers from among patients with psoriatic arthritis who are being followed at the study center's rheumatology clinic. The patient control group comprises volunteers diagnosed with psoriasis by a specialist dermatologist. Participants in the healthy control group are healthcare workers or patient companions matched for age and gender with the patient group and the patient control group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants with psoriatic arthritis
Diagnostic Test: OCTA-SCP · Diagnostic Test: OCTA-DCP · Diagnostic Test: OCTA-RPC · Diagnostic Test: OCTA-FAZ
Psoriasis participants with no other known systemic inflammatory disease
Diagnostic Test: OCTA-SCP · Diagnostic Test: OCTA-DCP · Diagnostic Test: OCTA-RPC · Diagnostic Test: OCTA-FAZ
Patient companions or hospital staff with no known chronic illnesses
Diagnostic Test: OCTA-SCP · Diagnostic Test: OCTA-DCP · Diagnostic Test: OCTA-RPC · Diagnostic Test: OCTA-FAZ
Vessel density of retinal superficial capillary plexus
Vessel density of retinal deep capillary plexus
Vessel density of retinal prepapillary capillaries
FAZ essessment parameters
Retinal SCP, VD
Vessel density of retinal superficial capillary plexus
Time frame: 1 day
Retinal DCP, VD
Vessel density of retinal deep capillary plexus
Time frame: 1 day
Retinal RCP, VD
Vessel density of retinal prepapillary capillaries
Time frame: 1 day
FAZ parameters
Foveal avasculary assessment parameters
Time frame: 1 day
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Aug 2027, 11 months after the start.
Of 77 non-industry observational studies under Arthritis, Psoriatic, half reached primary completion within 53 months of starting (the median), counting those still running; a quarter within 20. This study's planned 11 months is below that.
Counting every sponsor, half of 129 studies reached it within 47 months; a quarter within 28 and three quarters within 82.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bursa Yuksek Ihtisas Training and Research Hospital